DK0545195T3 - Indolopyrrolocarbazolderivater - Google Patents

Indolopyrrolocarbazolderivater

Info

Publication number
DK0545195T3
DK0545195T3 DK92119904.8T DK92119904T DK0545195T3 DK 0545195 T3 DK0545195 T3 DK 0545195T3 DK 92119904 T DK92119904 T DK 92119904T DK 0545195 T3 DK0545195 T3 DK 0545195T3
Authority
DK
Denmark
Prior art keywords
substd
opt
carboxyl
alkyl
carbamoyl
Prior art date
Application number
DK92119904.8T
Other languages
Danish (da)
English (en)
Inventor
Kojiri Katsuhisa
Kondo Hisao
Arakawa Hiroharu
Mitsuru Ohkubo
Suda Hiroyuki
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of DK0545195T3 publication Critical patent/DK0545195T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92119904.8T 1991-11-29 1992-11-23 Indolopyrrolocarbazolderivater DK0545195T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34191691 1991-11-29
JP6926992 1992-02-18
JP25730692 1992-09-01

Publications (1)

Publication Number Publication Date
DK0545195T3 true DK0545195T3 (da) 1995-12-18

Family

ID=27300000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92119904.8T DK0545195T3 (da) 1991-11-29 1992-11-23 Indolopyrrolocarbazolderivater

Country Status (27)

Country Link
EP (1) EP0545195B1 (es)
JP (1) JP2629542B2 (es)
KR (1) KR100275976B1 (es)
AT (1) ATE130617T1 (es)
AU (1) AU650376B2 (es)
BG (1) BG61036B1 (es)
CA (1) CA2083534C (es)
CZ (1) CZ287304B6 (es)
DE (1) DE69206242T2 (es)
DK (1) DK0545195T3 (es)
DZ (1) DZ1634A1 (es)
ES (1) ES2079774T3 (es)
FI (1) FI106864B (es)
GR (1) GR3018527T3 (es)
HU (3) HU217611B (es)
IL (1) IL103844A (es)
MX (1) MX9206847A (es)
MY (1) MY114655A (es)
NO (1) NO178929C (es)
NZ (1) NZ245203A (es)
PL (1) PL171468B1 (es)
RO (1) RO113469B1 (es)
RU (1) RU2117671C1 (es)
SA (1) SA93130351B1 (es)
TW (1) TW224469B (es)
WO (1) WO1993011145A1 (es)
YU (1) YU48963B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0760375T3 (da) * 1994-05-09 2003-12-29 Banyu Pharma Co Ltd Antitumor-indolopyrrolocarbazolderivater
WO1995030682A1 (fr) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
USRE37206E1 (en) * 1994-06-13 2001-06-05 Banyu Pharmaceutical Co, Ltd Gene encoding glycosyltransferase and its uses
WO1996004293A1 (fr) * 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
ES2169414T3 (es) * 1996-08-22 2002-07-01 Bristol Myers Squibb Co Amino-azucar citotoxico y derivados de azucares relacionados de indolopirrolocarbazoles.
GB9811624D0 (en) * 1998-05-29 1998-07-29 Merck Sharp & Dohme Therapeutic use
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6703373B1 (en) 1999-09-10 2004-03-09 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives and antitumor agents
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2001234119A1 (en) 2000-02-24 2001-09-03 Banyu Pharmaceutical Co. Ltd. Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6555677B2 (en) 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
CZ20032876A3 (en) 2001-03-22 2004-03-17 Bristol-Myers Squibb Company Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
US6559299B2 (en) 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides
WO2003080077A1 (fr) * 2002-03-26 2003-10-02 Banyu Pharmaceutical Co., Ltd. Utilisation combinee de derives anticancereux de l'indolopyrrolocarbazole et d'un autre agent anticancereux
CA2398828A1 (en) 2002-08-09 2004-02-09 Merck & Co., Inc. A pharmaceutical composition containing an indolopyrrolocarbazole derivative
WO2005010017A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd インドロピロロカルバゾール誘導体及び抗腫瘍剤
AU2004272457A1 (en) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. Novel indolopyrrolocarbazole derivative with antitumor activity
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
US7241779B2 (en) * 2003-12-23 2007-07-10 Cephalon, Inc. Fused pyrrolocarbazoles
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
MX2011005055A (es) 2008-11-19 2011-05-31 Cephalon Inc Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2037596C (en) * 1990-03-06 1995-07-18 Kin Sing Lam Rebeccamycin analog by bromide precursor feeding
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CA2083534A1 (en) 1993-05-30
EP0545195B1 (en) 1995-11-22
PL304729A1 (en) 1995-01-09
KR100275976B1 (ko) 2001-02-01
RU2117671C1 (ru) 1998-08-20
JP2629542B2 (ja) 1997-07-09
YU48963B (sh) 2003-01-31
ES2079774T3 (es) 1996-01-16
CZ287304B6 (cs) 2000-10-11
CZ350892A3 (en) 1993-10-13
WO1993011145A1 (en) 1993-06-10
FI106864B (fi) 2001-04-30
IL103844A0 (en) 1993-04-04
AU2963792A (en) 1993-06-03
PL171468B1 (pl) 1997-05-30
IL103844A (en) 1997-09-30
HU217611B (hu) 2000-03-28
EP0545195A1 (en) 1993-06-09
NO178929C (no) 1996-07-03
TW224469B (es) 1994-06-01
FI925422A0 (fi) 1992-11-27
DE69206242D1 (de) 1996-01-04
DZ1634A1 (fr) 2002-02-17
HU211254A9 (en) 1995-11-28
DE69206242T2 (de) 1996-03-28
NZ245203A (en) 1997-07-27
YU102692A (sh) 1996-02-19
RO113469B1 (ro) 1998-07-30
KR930010039A (ko) 1993-06-21
HU9203754D0 (en) 1993-03-29
BG97970A (bg) 1994-04-29
CA2083534C (en) 2003-01-28
NO178929B (no) 1996-03-25
BG61036B1 (bg) 1996-09-30
SA93130351B1 (ar) 2005-10-16
JPH06128283A (ja) 1994-05-10
NO924593L (no) 1993-06-01
HUT65699A (en) 1994-07-28
NO924593D0 (no) 1992-11-27
FI925422A (fi) 1993-05-30
MY114655A (en) 2002-12-31
MX9206847A (es) 1993-06-30
ATE130617T1 (de) 1995-12-15
AU650376B2 (en) 1994-06-16
GR3018527T3 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
DE69206242D1 (de) Indolopyrrolocarbazolederivate.
ES470134A1 (es) Un procedimiento para la produccion de derivados sustituidosde ciclohexano-1,3-diona
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
NZ514662A (en) Amine derivatives
GB1402498A (en) Triazine derivatives their production and their medicinal use
ES435819A1 (es) Procedimiento para preparar derivados de 1-(4-fenoxi-fenil)-1, 3, 5-triazina.
ES2002012A6 (es) Procedimiento para preparar (1,2,4)triazol (1,5-c)pirimidinas e-fusionadas
EA200100422A1 (ru) Производные мононитрата изосорбида и их использование в качестве сосудорасширяющих агентов с пониженной толерантностью
MX9700928A (es) Derivado de triazian y medicina que lo contiene.
ES2021182A6 (es) Procedimiento para preparar derivados de capsaicina.
ES433462A1 (es) Un procedimiento de produccion de un derivado de pirazina.
ATE196137T1 (de) Thiazolin-derivate
ES457805A1 (es) Un procedimiento para la preparacion de derivados de tiou- rea.
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
ES459755A1 (es) Procedimiento para preparar carbamatos de oximas de deriva- dos del acido isonitrosocianocetico.
ES398417A1 (es) Procedimiento para la obtencion de esteres de acido fosfo- rico.
ES2133376T3 (es) Derivados de imidazol y su uso como agentes agroquimicos.
ES478049A1 (es) Procedimiento para preparar derivados de trifluormetilimino-tiazolidina.
TH5599A (th) อนุพันธุ์ของคาร์บาโมอิลลอกซีไธโอฟีน